Envision Pharma Group

Envision Pharma Group

Global provider of evidence-based communication services and industry-leading technology solutions serving pharmaceutical, biotech & medical device companies.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round

N/A

Buyout
Total Funding000k
Notes (0)
More about Envision Pharma Group
Made with AI
Edit

Envision Pharma Group operates in the life sciences sector, providing a comprehensive suite of services and technology solutions to support clients across the product life cycle. The company specializes in medical communications, commercialization, strategic consulting, and value access. Envision leverages advanced technologies such as artificial intelligence and natural language processing to enhance its service offerings. The company serves a diverse range of clients, including pharmaceutical companies, biotech firms, and healthcare organizations. Its business model revolves around offering tailored solutions that integrate scientific expertise with delivery excellence. Envision generates revenue through service contracts, consulting fees, and technology solutions. The company is particularly recognized for its capabilities in the Asian Pacific region through its ProScribe division, which is known for its medical communication services.

Keywords: life sciences, medical communications, AI, consulting, commercialization, biotech, healthcare, strategic solutions, ProScribe, technology.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Envision Pharma Group

Edit
Alligent Group
ACQUISITION by Envision Pharma Group Sep 2015
DoDOC
ACQUISITION by Envision Pharma Group Mar 2021
OKRA Technologies
ACQUISITION by Envision Pharma Group Feb 2023
Touch Creative Design
ACQUISITION by Envision Pharma Group Nov 2017
90TEN
ACQUISITION by Envision Pharma Group Apr 2020
Two Labs
ACQUISITION by Envision Pharma Group Nov 2020